Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Vascular Biology

Background:

• Ischemic vascular diseases pose significant health challenges.
• Therapeutic angiogenesis aims to restore blood flow through new blood vessel formation.
• Current treatments often require frequent drug administrations, limiting efficacy and patient compliance.

Purpose of the Study:

• To evaluate the efficacy of a novel microsphere/hydrogel combination system for controlled delivery of recombinant human Vascular Endothelial Growth Factor (rhVEGF).
• To assess the potential of this system in promoting therapeutic angiogenesis in an ischemic hindlimb mouse model.
• To determine if this approach can achieve therapeutic benefits without multiple administrations.

Main Methods:

• A combination system was developed using poly(d,l-lactide-co-glycolide) (PLGA) microspheres and alginate hydrogels loaded with rhVEGF.
• This rhVEGF-releasing system was administered via intramuscular injection into the ischemic hindlimb of a mouse model.
• Neovascularization and tissue protection in the ischemic region were evaluated.

Main Results:

• The microsphere/hydrogel system demonstrated controlled release of rhVEGF.
• Treatment effectively protected ischemic muscles from tissue necrosis.
• A significant increase in newly formed, active blood vessels was observed in the treated group.

Conclusions:

• The microsphere/hydrogel combination system is a viable strategy for delivering angiogenic factors.
• This delivery system holds potential for treating ischemic vascular diseases by promoting therapeutic angiogenesis.
• The controlled release mechanism may reduce the frequency of drug administration for vascular disease treatments.